Dulac Edward J III Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$2.87M

Insider Activity of Dulac Edward J III

According to the SEC Form 4 filings, Dulac Edward J III, being in a position of

  1. EVP, Chief Financial Officer at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 19167 shares for $234,185,
    over all time since 2025-07-23, has bought 0 shares, and sold 26629 shares for $338,803.

Biography of Dulac Edward J III

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $234,1853100

Comparison of Insiders on Amount of Buys and Sells

2026-07-22SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Financial Officer
8,111
0.0073%
$11.25$91,249+8%
2026-07-02SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Financial Officer
4,677
0.0043%
$18.00$84,186-31.41%
2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Financial Officer
6,379
0.006%
$9.21$58,751+36.93%
2025-07-23SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Financial Officer
7,462
0.0071%
$14.02$104,617-8.64%
2024-03-04SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
2,447
0.0027%
$7.77$19,013-51.55%
2024-01-29SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
1,849
0.0017%
$5.00$9,245-36.19%
2024-01-09SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
7,028
0.0071%
$4.37$30,712-14.74%
2024-01-02SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
5,182
0.0052%
$3.66$18,966+2.57%
2023-12-18SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
1,585
0.0018%
$3.50$5,548+20.63%
2023-08-18SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
4,718
0.0048%
$2.80$13,210+33.09%
2023-07-05SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
5,182
0.0053%
$4.83$25,029-23.46%
2023-01-10SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
7,331
0.0071%
$5.24$38,414-13.84%
2022-08-18SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
4,703
0.0048%
$29.75$139,914-80.09%
2022-01-11SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
1,770
0.0019%
$48.45$85,757-43.63%
2021-12-20SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
15,977
0.0168%
$60.00$958,620-51.66%
2021-09-28SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
19,460
0.021%
$62.53$1.22M-42.11%
2021-08-19SaleFate Therapeutics, Inc.
FATE
Chief Financial Officer
3,474
0.0038%
$88.26$306,602-55.38%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.